Search Results - "Larive, A."

Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension by Balasubramanian, Aparna, Larive, A. Brett, Horn, Evelyn M., DuBrock, Hilary M., Mehra, Reena, Jacob, Miriam S., Hemnes, Anna R., Leopold, Jane A., Radeva, Milena K., Hill, Nicholas S., Erzurum, Serpil C., Rosenzweig, Erika B., Frantz, Robert P., Rischard, Franz P., Beck, Gerald J., Hassoun, Paul M., Mathai, Stephen C.

“…Health-related quality of life (HRQOL) is frequently impaired in pulmonary arterial hypertension. However, little is known about HRQOL in other forms of…”
Get full text

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension by Rischard, Franz P, Bernardo, Roberto J, Vanderpool, Rebecca R, Kwon, Deborah H, Acharya, Tushar, Park, Margaret M, Katrynuik, Austin, Insel, Michael, Kubba, Saad, Badagliacca, Roberto, Larive, A Brett, Naeije, Robert, Garcia, Joe G N, Beck, Gerald J, Erzurum, Serpil C, Frantz, Robert P, Hassoun, Paul M, Hemnes, Anna R, Hill, Nicholas S, Horn, Evelyn M, Leopold, Jane A, Rosenzweig, Erika B, Tang, W H Wilson, Wilcox, Jennifer D

“…Normative changes in right ventricular (RV) structure and function have not been characterized in the context of treatment-associated functional recovery (RV…”
Get full text

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study by Frantz, Robert P., Leopold, Jane A., Hassoun, Paul M., Hemnes, Anna R., Horn, Evelyn M., Mathai, Stephen C., Rischard, Franz P., Larive, A. Brett, Tang, W.h. Wilson, Park, Margaret M., Hill, Nicholas S., Rosenzweig, Erika B.

“…Chronic thromboembolic pulmonary hypertension (CTEPH) is believed to involve both vascular obstruction and vasoconstriction; hence, pulmonary vasodilators such…”
Get full text

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study by Naranjo, Mario, Rosenzweig, Erika B, Hemnes, Anna R, Jacob, Miriam, Desai, Ankit, Hill, Nicholas S, Larive, A Brett, Finet, J Emanuel, Leopold, Jane, Horn, Evelyn, Frantz, Robert, Rischard, Franz, Erzurum, Serpil, Beck, Gerald, Mathai, Stephen C, Hassoun, Paul M

“…The prevalence of acute vasodilator response (AVR) to inhaled nitric oxide (iNO) during right heart catheterization (RHC) is 12% in idiopathic pulmonary…”
Get full text

Association of Male Sex With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort by Shelburne, Nicholas J., Nian, Hui, Beck, Gerald J., Casanova, Nancy G., Desai, Ankit A., DuBrock, Hilary M., Erzurum, Serpil, Frantz, Robert P., Hassoun, Paul M., Hill, Nicholas S., Horn, Evelyn M., Jacob, Miriam S., Jellis, Christine L., Joseloff, Elizabeth, Kwon, Deborah H., Larive, A. Brett, Leopold, Jane A., Park, Margaret M., Rischard, Franz P., Rosenzweig, Erika B., Vanderpool, Rebecca R., Yu, Chang, Hemnes, Anna R.

“…Sex-based differences are important in the development and progression of pulmonary arterial hypertension. However, it is not established whether these…”
Get full text

Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure by Kanagasundaram, Nigel S., Greene, T.O.M., Larive, A. Brett, Daugirdas, John T., Depner, Thomas A., Garcia, Michelle, Paganini, Emil P., on behalf of the Project for the Improvement of the Care of Acute Renal Dysfunction (PICARD) Study Group

“…Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure. Prospective, formal, blood-side, urea kinetic modeling…”
Get full text

A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis by Kanagasundaram, N S, Larive, A B, Paganini, E P

“…The problem of dialysate bacterial contamination has not been defined in continuous renal replacement therapy. We assessed the bacterial integrity of source…”
Get more information

A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis by Kanagasundaram, Nigel S., Larive, A. Brett, Paganini, Emil P.

“…A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis. Technical Note. Fractional direct dialysis…”
Get full text

Intraoperative cystoscopy in conjunction with anti-incontinence surgery by Tulikangas, Paul K, Weber, Anne M, Larive, A.Brett, Walters, Mark D

“…Objective: To determine the frequency of lower urinary tract injury detected by routine intraoperative cystoscopy after anti-incontinence surgery. Methods: We…”
Get full text

Recent progress in robot-based systems for crystallography and their contribution to drug discovery by Ferrer, Jean-Luc, Larive, Nathalie A, Bowler, Matthew W, Nurizzo, Didier

“…X-ray crystallography is the main tool for macromolecular structure solution at atomic resolution. It provides key information for the understanding of protein…”
Get more information

2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study by Rodriguez, J.E., Danlos, F-X., Larive, A., Marabelle, A., Frelaut, M., Tagliamento, M., Aldea, M., Besse, B., Micol, J. Baptiste, Aix, S. Ponce, Marzac, C., Chaput-Gras, N., Massard, C., Baldini, C.

Get full text

653O Neoadjuvant nivolumab (N) before chemoradiation (CRT) in high-risk HPV driven oropharynx cancer (OPC) - IMMUNEBOOST-HPV: A multicenter randomized phase II trial by Mirghani, H., Even, C., Larive, A., Pere, H., Fayette, J., Geoffrois, L., Clatot, F., Calderon, B., Tao, Y., Nguyen, T.V.F., Fabiano, E., Kreps, S., Veyer, D., Puech, J., Badoual, C., Garic, F., Auperin, A., Blanchard, P.

Get full text

Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease by Hemnes, Anna R., Leopold, Jane A., Radeva, Milena K., Beck, Gerald J., Abidov, Aiden, Aldred, Micheala A., Barnard, John, Rosenzweig, Erika B., Borlaug, Barry A., Chung, Wendy K., Comhair, Suzy A.A., Desai, Ankit A., Dubrock, Hilary M., Erzurum, Serpil C., Finet, J. Emanuel, Frantz, Robert P., Garcia, Joe G.N., Geraci, Mark W., Gray, Michael P., Grunig, Gabriele, Hassoun, Paul M., Highland, Kristin B., Hill, Nicholas S., Hu, Bo, Kwon, Deborah H., Jacob, Miriam S., Jellis, Christine L., Larive, A. Brett, Lempel, Jason K., Maron, Bradley A., Mathai, Stephen C., McCarthy, Kevin, Mehra, Reena, Nawabit, Rawan, Newman, John H., Olman, Mitchell A., Park, Margaret M., Ramos, Jose A., Renapurkar, Rahul D., Rischard, Franz P., Sherer, Susan G., Tang, W.H. Wilson, Thomas, James D., Vanderpool, Rebecca R., Waxman, Aaron B., Wilcox, Jennifer D., Yuan, Jason X.-J., Horn, Evelyn M.

“…PVDOMICS (Pulmonary Vascular Disease Phenomics) is a precision medicine initiative to characterize pulmonary vascular disease (PVD) using deep phenotyping…”
Get full text

Direct dialysis quantification: investigation of the impact of dialysate preservation techniques on solute assays by Kanagasundaram, Nigel S, Posch, Amy, Larive, A Brett, Paganini, Emil P, Van Lente, Frederick

“…Urease-producing microorganisms may lower urea nitrogen (UN) during dialysate-side dosing. We investigated the impact of 3 proven preservatives (acetic acid,…”
Get more information

234P Germline mutations in index patients with ductal carcinoma in situ (DCIS): A single center retrospective study by Ouali, K., Verret, B., Wehrer, D., Goldbarg, V., Larive, A., Joulia, M-L., Villebasse, S., Di Maria, M., Delaloge, S., Caron, O.

Get full text

Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome by Desnoyer, A., Larive, A., Drubay, D., Lanoy, E., Vano, Y., Rioux-Leclercq, N., Chouaib, S., Beuselinck, B., Tantot, F., Escudier, B., Chaput, N., Albiges, L.

Get full text

972P - Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome by Desnoyer, A., Larive, A., Drubay, D., Lanoy, E., Vano, Y., Rioux-Leclercq, N., Chouaib, S., Beuselinck, B., Tantot, F., Escudier, B., Chaput, N., Albiges, L.

“…The NIVOREN GETUG-AFU 26 study reported safety and efficacy of nivolumab in patients with RCC in a “real world setting”. A translational research program was…”
Get full text

972PFresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome by Desnoyer, A, Larive, A, Drubay, D, Lanoy, E, Vano, Y, Rioux-Leclercq, N, Chouaib, S, Beuselinck, B, Tantot, F, Escudier, B, Chaput, N, Albiges, L

“…Abstract Background The NIVOREN GETUG-AFU 26 study reported safety and efficacy of nivolumab in patients with RCC in a “real world setting”. A translational…”
Get full text

Plasma protein variations in monozygotic twins discordant for schizophrenia by Vander Putten, Dale M., Fuller Torrey, E., Brett Larive, A., Merril, Carl R.

“…Monozygotic twins discordant for schizophrenia were analyzed by two-dimensional (2-D) gel electrophoresis to identify extrahereditary factors important in the…”
Get full text

Clonal Hematopoiesis of indeterminate potential in patients with advanced NSCLC treated with ICB by Rodriguez, J.E., Danlos, F.X., Larive, A., Marabelle, A., Frelaut, M., Tagliamento, M., Aldea, M., Besse, B., Micol, J.B., Marzac, C., Chaput-Gras, N., Massard, C., Baldini, C.

Get full text